**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 65-30-5 |Nicotine sulfate | 40 | 200-606-7 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | 60 | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T+ N
Risk Phrases: 26/27/28 51/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Very toxic by inhalation, in contact with skin and if swallowed.
Toxic to aquatic organisms, may cause long-term adverse effects in
the aquatic environment.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be fatal if absorbed through the
skin.
Ingestion:
May be fatal if swallowed. May cause irritation of the digestive
tract. May cause central nervous system stimulation.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation. May
cause lung damage.
Chronic:
Adverse reproductive effects have been reported in animals. May
cause lung damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse. Destroy contaminated shoes. Remove all contaminated
clothing immediately.
Ingestion:
Call a poison control center. If swallowed, do not induce vomiting
unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Get medical aid.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Use extinguishing media
appropriate to the surrounding fire. Substance is noncombustible.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas. Containers may explode when heated.
Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Do NOT use straight streams of water. For small fires, use dry
chemical, carbon dioxide, or water spray. For large fires, use water
spray, fog or regular foam. Cool containers with flooding quantities
of water until well after fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid contact with
eyes, skin, and clothing. Keep container tightly closed. Avoid
ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Poison room
locked.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 65-30-5:
Russia: 0.1 mg/m3 TWA
CAS# 7732-18-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Viscous liquid
Color: brown
Odor: sulfurous odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density: 1.15 @ 20C
Molecular Formula: C10H14N2.0.5H2SO4
Molecular Weight: 211.27
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Extreme temperatures.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 65-30-5: QS9625000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
CAS# 65-30-5: Inhalation, rat: LC50 = 22 mg/m3; Oral, mouse: LD50 =
8550 ug/kg; Oral, rat: LD50 = 50 mg/kg; Skin, rabbit: LD50 = 50
mg/kg; Skin, rat: LD50 = 285 mg/kg.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Nicotine sulfate -
Not listed by ACGIH, IARC, or NTP.
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: NICOTINE SULPHATE SOLUTION
Hazard Class: 6.1
UN Number: 1658
Packing Group: II
IMO
Shipping Name: NICOTINE SULPHATE SOLUTION
Hazard Class: 6.1
UN Number: 1658
Packing Group: II
RID/ADR
Shipping Name: NICOTINE SULPHATE SOLUTION
Hazard Class: 6.1
UN Number: 1658
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+ N
Risk Phrases:
R 26/27/28 Very toxic by inhalation, in contact with
skin and if swallowed.
R 51/53 Toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 13 Keep away from food, drink and animal feeding
stuffs.
S 28A After contact with skin, wash immediately with
plenty of water.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 65-30-5: No information available.
CAS# 7732-18-5: No information available.
Canada
CAS# 65-30-5 is listed on Canada's DSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 65-30-5 is not listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 65-30-5 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 7/29/1999 Revision #3 Date: 12/03/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Sulfamic acid
| 5329-14-6 |
|
3-Chlorocinnamic Acid, Predominantly Trans 99+%
| 1866-38-2 |
|
4-(Bromomethyl)-7-Methoxycoumarin 99%
| 35231-44-8 |
|
2-Hydroxy-3-nitropyridine, 98%
| 6332-56-5 |
|
Sulfanilamide
| 63-74-1 |
|
Sulfanilic acid
| 121-57-3 |
|
Nicotine sulfate, 40% aqueous solution
| 65-30-5 |
|
2-Bromobenzaldehyde, 97%
| 6630-33-7 |
|
Bicyclo (3.2.1)Octan-2-One, 90-95%(GC)
| 5019-82-9 |
|
Benzo??b??naphtho??2,3-d??thiophene, 99.5+%
| 243-46-9 |
|
Triethyl Orthoacetate, 99% (GC)
| 78-39-7 |
|
5-Sulfosalicylic acid dihydrate
| 97-05-2 |
|
4-Benzoyloxy-2-Azetidinone, 99%
| 28562-58-5 |
|
Sulfur (Precipitated and Sublimed)
| 7704-34-9 |
|
N-Methyl-Beta-Alaninenitrile, 98%
| 693-02-7 |
|
Trimethyl Orthovalerate
| 13820-09-2 |
|
Ethyl diethoxyphosphinylformate, 98%
| 1474-78-8 |
|
S-Methyl-L-Cysteine, 99+%
| 1187-84-4 |
|
N-Benzoyl-4-Piperidone, 97%
| 24686-78-0 |
|
Succinimide, 99%
| 123-56-8 |
|
Sulfuric acid 90-98%
| 7664-93-9 |
|
Sulfurous Acid
| 7782-99-2 |
|
Silver trifluoromethanesulfonate, 99+%
| 2923-28-6 |
|
Rhodanine-n-acetic acid, 98%
| 5718-83-2 |
|
Tannic Acid
| 1401-55-4 |
|
Diphenic Anhydride, 98%
| 6050-13-1 |
|
4-(Dimethylamino)butyric Acid Hydrochloride, 98%
| 69954-66-1 |
|
(4S,5S)-4,5-Di(aminomethyl)-2,2-dimethyldioxolane, 99+%
| 119322-88-2 |
|
4-Acryloylamidobenzo-18-Crown-6, 98%
| 0-00-1 |
|
2-Thio-6-hydroxypurine hydrate, 98%
| 2487-40-3 |
|
3-Methyl-4-nitrobenzoic acid, 99%
| 3113-71-1 |
|
L-(+)-Tartaric acid
| 87-69-4 |
|
3-Methyl-2-pyrazolin-5-one, 99% (titr.)
| 108-26-9 |
|
2-Nitronaphthalene, tech., 85%
| 581-89-5 |
|
2,6-Dibromopyridine, 98%
| 626-05-1 |
|
5-Methylfurfural, 98+%
| 620-02-0 |
|
Ammonium orthoarsenate trihydrate, 99.999%
| 13477-86-6 |
|
n-Benzylglycine ethyl ester hydrochloride, 98%
| |
|
N-Alpha-Acetyl-L-Lysine-N-Methylamide Monohydrate, 99+%, (TLC)
| 81013-00-5 |
|
(+)-Dimethyl L-Tartrate, 99%
| 608-68-4 |
|
2,5-Dibromotoluene, 99%
| 615-59-8 |
|
2-Aminoperimidine, Hydrobromide Sesquihydrate, 98%
| 40835-96-9 |
|
Nucleic Acid (Pract), 90% (UV-VIS)
| 9008-72-4 |
|
Ethyl 3-Endo-Aminobicyclo[2.2.1]Hept-5-ene -2-Endo-Carboxylate
| 95630-74-3 |
|
Cyclopentanemethanol, 96%
| 3637-61-4 |
|
Tetrahexylammonium Bromide, 99% (Titr.)
| 4328-13-6 |
|
1-(4-Chlorophenyl)-1-cyclohexanecarbonitrile
| |
|
Potassium deuteroxide, 40 wt% solution in d2o, 98+ atom % d
| 24572-01-8 |
|
1-(2-Methoxyphenyl)piperazine, 98+% (GC)
| 35386-24-4 |
|
4-Carboxybenzo-15-Crown-5, 99+%
| 0-00-1 |
|
|